XML 79 R60.htm IDEA: XBRL DOCUMENT v3.25.4
Net Loss Per Share - Computation (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Numerator:    
Net loss $ (66,458) $ (61,183)
Net loss attributable to noncontrolling interest 30 109
Net loss attributable to Barinthus Biotherapeutics plc shareholders $ (66,428) $ (61,074)
Denominator:    
Weighted-average ordinary shares outstanding, basic (in shares) 40,527,218 39,348,240
Weighted-average ordinary shares outstanding, diluted (in shares) 40,527,218 39,348,240
Net loss per share attributable to ordinary shareholders, basic (in usd per share) $ (1.64) $ (1.55)
Net loss per share attributable to ordinary shareholders, diluted (in usd per share) $ (1.64) $ (1.55)